scGPT – end-to-end protocol for fine-tuned retinal cell type annotation

by Biotech Newsroom


Single-cell RNA sequencing (scRNA-seq) has changed the way researchers study cells by allowing them to examine gene expression at the level of individual cells. This technology helps uncover subtle differences between cell types, identify rare cells, and track how cells change over time. However, the growing scale of scRNA-seq datasets makes it increasingly difficult to accurately and efficiently label or annotate these cell types, especially when researchers are working with complex tissues like the retina.

To solve this problem,…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC